No Cover Image

Journal article 782 views 86 downloads

“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm

Luke Cox Orcid Logo, Timothy Piatkowski, Jim McVeigh Orcid Logo

Drugs: Education, Prevention and Policy, Pages: 1 - 13

Swansea University Author: Luke Cox Orcid Logo

  • 66902.vor.pdf

    PDF | Version of Record

    © 2024 the author(s). This is an open access article distributed under the terms of the creative commons attribution-noncommercial-noDerivatives license ,which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in anyway.

    Download (1.63MB)

Abstract

Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Respondin...

Full description

Published in: Drugs: Education, Prevention and Policy
ISSN: 0968-7637 1465-3370
Published: Informa UK Limited 2024
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa66902
first_indexed 2024-06-27T09:45:23Z
last_indexed 2024-12-04T19:45:32Z
id cronfa66902
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2024-12-04T15:46:43.6637174</datestamp><bib-version>v2</bib-version><id>66902</id><entry>2024-06-27</entry><title>&#x201C;I would never go to the doctor and speak about steroids&#x201D;: Anabolic androgenic steroids, stigma and harm</title><swanseaauthors><author><sid>9811ac84cad867903c385bf7086dfd2d</sid><ORCID>0000-0001-7625-4603</ORCID><firstname>Luke</firstname><surname>Cox</surname><name>Luke Cox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-06-27</date><deptcode>EAAS</deptcode><abstract>Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them.Method Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS.Results PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions.Conclusions Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS.</abstract><type>Journal Article</type><journal>Drugs: Education, Prevention and Policy</journal><volume>0</volume><journalNumber/><paginationStart>1</paginationStart><paginationEnd>13</paginationEnd><publisher>Informa UK Limited</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0968-7637</issnPrint><issnElectronic>1465-3370</issnElectronic><keywords>Keywords: Anabolic androgenic steroids, image and performance enhancing drugs, stigma, harm reduction, needle and syringe program</keywords><publishedDay>14</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-07-14</publishedDate><doi>10.1080/09687637.2024.2373056</doi><url/><notes/><college>COLLEGE NANME</college><department>Engineering and Applied Sciences School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>EAAS</DepartmentCode><institution>Swansea University</institution><apcterm>SU Library paid the OA fee (TA Institutional Deal)</apcterm><funders>Swansea University</funders><projectreference/><lastEdited>2024-12-04T15:46:43.6637174</lastEdited><Created>2024-06-27T10:43:24.2549457</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Engineering and Applied Sciences - Sport and Exercise Sciences</level></path><authors><author><firstname>Luke</firstname><surname>Cox</surname><orcid>0000-0001-7625-4603</orcid><order>1</order></author><author><firstname>Timothy</firstname><surname>Piatkowski</surname><order>2</order></author><author><firstname>Jim</firstname><surname>McVeigh</surname><orcid>0000-0001-5319-6885</orcid><order>3</order></author></authors><documents><document><filename>66902__30912__793c9a8409394b2db08eefc4b171aea5.pdf</filename><originalFilename>66902.vor.pdf</originalFilename><uploaded>2024-07-16T10:35:44.8401191</uploaded><type>Output</type><contentLength>1705876</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; 2024 the author(s). This is an open access article distributed under the terms of the creative commons attribution-noncommercial-noDerivatives license ,which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in anyway.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2024-12-04T15:46:43.6637174 v2 66902 2024-06-27 “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm 9811ac84cad867903c385bf7086dfd2d 0000-0001-7625-4603 Luke Cox Luke Cox true false 2024-06-27 EAAS Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them.Method Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS.Results PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions.Conclusions Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS. Journal Article Drugs: Education, Prevention and Policy 0 1 13 Informa UK Limited 0968-7637 1465-3370 Keywords: Anabolic androgenic steroids, image and performance enhancing drugs, stigma, harm reduction, needle and syringe program 14 7 2024 2024-07-14 10.1080/09687637.2024.2373056 COLLEGE NANME Engineering and Applied Sciences School COLLEGE CODE EAAS Swansea University SU Library paid the OA fee (TA Institutional Deal) Swansea University 2024-12-04T15:46:43.6637174 2024-06-27T10:43:24.2549457 Faculty of Science and Engineering School of Engineering and Applied Sciences - Sport and Exercise Sciences Luke Cox 0000-0001-7625-4603 1 Timothy Piatkowski 2 Jim McVeigh 0000-0001-5319-6885 3 66902__30912__793c9a8409394b2db08eefc4b171aea5.pdf 66902.vor.pdf 2024-07-16T10:35:44.8401191 Output 1705876 application/pdf Version of Record true © 2024 the author(s). This is an open access article distributed under the terms of the creative commons attribution-noncommercial-noDerivatives license ,which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in anyway. true eng http://creativecommons.org/licenses/by-nc-nd/4.0/
title “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
spellingShingle “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox
title_short “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
title_full “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
title_fullStr “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
title_full_unstemmed “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
title_sort “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
author_id_str_mv 9811ac84cad867903c385bf7086dfd2d
author_id_fullname_str_mv 9811ac84cad867903c385bf7086dfd2d_***_Luke Cox
author Luke Cox
author2 Luke Cox
Timothy Piatkowski
Jim McVeigh
format Journal article
container_title Drugs: Education, Prevention and Policy
container_volume 0
container_start_page 1
publishDate 2024
institution Swansea University
issn 0968-7637
1465-3370
doi_str_mv 10.1080/09687637.2024.2373056
publisher Informa UK Limited
college_str Faculty of Science and Engineering
hierarchytype
hierarchy_top_id facultyofscienceandengineering
hierarchy_top_title Faculty of Science and Engineering
hierarchy_parent_id facultyofscienceandengineering
hierarchy_parent_title Faculty of Science and Engineering
department_str School of Engineering and Applied Sciences - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Engineering and Applied Sciences - Sport and Exercise Sciences
document_store_str 1
active_str 0
description Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them.Method Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS.Results PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions.Conclusions Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS.
published_date 2024-07-14T20:32:16Z
_version_ 1821348343186456576
score 11.04748